Mineralys Therapeutics, Inc. · NASDAQ:MLYS

Congleton Jon sold 10,700 Mineralys Therapeutics, Inc. shares (Form 4)

Traded Jul 13, 2026 · Filed Jul 15, 2026

On Jul 13, 2026, Congleton Jon (Director, Chief Executive Officer) sold 10,700 Mineralys Therapeutics, Inc. shares at US$27.24 for US$291K under a trading plan, leaving 603,621 shares. Filed Jul 15, 2026 (Form 4).

Sold
10,700 shares
Price
US$27.24
Value
US$291K
Holding after
603,621 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 13, 2026Common StockSale10,700US$27.24603,621Direct

Source

View original at SEC

Related